Symposium on Clinical Interventional Oncology (CIO 2018)

 

Symposium on Clinical Interventional Oncology (CIO 2018)
Avatar

Declaring Mistrials: What to Make of the Negative IO Studies and Other Literature Conundrums - SARAH/SIRVENIB Trials

By Symposium on Clinical Interventional Oncology (CIO 2018) FEATURING William Rilling
By Symposium on Clinical Interventional Oncology (CIO 2018) FEATURING William Rilling
0 views
January 4, 2019
Comments 0
Login to view comments. Click here to Login
Session 2
10:24
Symposium on Clinical Interventional Oncology (CIO 2018)

The Big Picture: The Value of IO in a Major Cancer Center

08:24
Symposium on Clinical Interventional Oncology (CIO 2018)

Review of the SIRFLOX-FOXFIRE Trials

Feat. S. Padia
05:06
Symposium on Clinical Interventional Oncology (CIO 2018)

Declaring Mistrials: What to Make of the Negative IO Studies and Oth…

Feat. R. Salem
09:13
Symposium on Clinical Interventional Oncology (CIO 2018)

Transarterial Trials with Potential Confounders

Feat. K. Brown
05:21
Symposium on Clinical Interventional Oncology (CIO 2018)

Declaring Mistrials: What to Make of the Negative IO Studies and Oth…

04:49
Symposium on Clinical Interventional Oncology (CIO 2018)

Interpreting Trials: Local Treatment of Unresectable Colorectal Live…

Feat. D. Sze
31:36
Symposium on Clinical Interventional Oncology (CIO 2018)

Buzzkill Corner: The Existential Threats to Interventional Oncology …

Feat. C. Ray
05:21
Symposium on Clinical Interventional Oncology (CIO 2018)

Declaring Mistrials: What to Make of the Negative IO Studies and Oth…

Feat. W. Rilling